{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 486"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and Cosmetic Act to\n\t\t  incentivize the development of abuse-deterrent drugs."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130204", "#text": "February 4, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee\n\t\t\t on Energy and Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Keating", "@name-id": "K000375"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Mr. Rogers of Kentucky", "@name-id": "R000395"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Rahall", "@name-id": "R000011"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Lynch", "@name-id": "L000562"}, {"#tail": ", and\n\t\t\t ", "#text": "Ms. Hanabusa", "@name-id": "H001050"}, {"#tail": ") introduced the following\n\t\t\t bill; which was referred to the ", "#text": "Mr. Buchanan", "@name-id": "B001260"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H450D3C1CFC514EE99D64A31F14657AF7", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Stop Tampering of Prescription Pills\n\t\t\t Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HEB2D656A155F4AA3A57AC6F3C696A1C1"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Abuse-deterrent\n\t\t\t technology"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by\n\t\t\t adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 201 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 321", "@value": "usc/21/321"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Definition"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": "\n\t\t\t\tmeans a drug that\u2014", "#text": "abuse-deterrent drug"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(ss)"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 102 of the Controlled\n\t\t\t\tSubstances Act", "@value": "Controlled Substances Act/s:102"}, "#text": "contains as an active moiety a controlled\n\t\t\t\tsubstance that has been classified as opium, an opiate, or a derivative\n\t\t\t\tthereof, as such terms are defined or used in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H21100A91AD6A4A0E9612888E0EC9AD97", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "has been\n\t\t\t\tformulated for oral administration; and"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "HC6E723FACCF548618AF1DA1228E0E500", "#text": "\n              "}, {"#tail": "\n          ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ") that make\n\t\t\t\tproduct manipulation significantly more difficult or ineffective in altering\n\t\t\t\tthe characteristics of the drug for purposes of misuse or abuse when compared\n\t\t\t\tto drugs without such properties; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "exhibits physicochemical\n\t\t\t\tproperties (demonstrated by in vitro, in vivo, or other testing, or some\n\t\t\t\tcombination thereof, as determined appropriate by the "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n                ", "@id": "H0BAC295E4E524BDEB187AE53C0C9CF32", "@commented": "no"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "contains one or more additional active or\n\t\t\t\tinactive ingredients that are intended to deter abuse through potential\n\t\t\t\tpharmacological effects, the effectiveness of which has been demonstrated by at\n\t\t\t\tleast one adequate and well-controlled\n\t\t\t\tinvestigation.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "HC00B4CF28BCE4369B55F02E49AB1FFE9"}], "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "HAAF52076375440EFADA74BF1E67F8793", "#text": "\n              "}], "#text": "\n            ", "@id": "H9351D65F92E641FF8150A7BE792D2D84"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H2C037AA9ABE54605A8348AE890E1936D"}, "#text": "\n        ", "@id": "H20A31161C93F4357A81EB6BA0C607B3B"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t (", "@entity-type": "act", "#text": "Section 505(b) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 355(b)", "@value": "usc/21/355/b"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Required\n\t\t\t information in application for approval of brand name\n\t\t\t drugs"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the application shall\n\t\t\t\tinclude such information as the ", "@entity-type": "act", "#text": "subsection (d)(7)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:d/p:7"}, {"#tail": " determines necessary to demonstrate\n\t\t\t\tthat the application is not subject to such\n\t\t\t\trefusal.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If an application submitted under this subsection is\n\t\t\t\tpotentially subject to refusal under "}, "enum": {"#tail": "\n            ", "#text": "(7)"}, "header": {"#tail": "\n            ", "#text": "Abuse-deterrent\n\t\t\t\tdrugs"}, "#text": "\n            ", "@id": "HF9FC42D7F6A348ACBB48B97009B070F7"}, "#text": "\n\t\t\t\t\t", "@id": "H9E03DA65ACC846A78694AC662FDC622B"}, "#text": "\n        ", "@id": "H9D8A55AF022946FE92A49B14963E444E"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 505(d) of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:d"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 355(d)", "@value": "usc/21/355/d"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Approval of new\n\t\t\t brand name drugs"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " after ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "; (C) such drug\n\t\t\t is not an abuse-deterrent drug; and (D) the ", "@entity-type": "act", "#text": "section 102 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:102"}, {"#tail": " has previously approved\n\t\t\t pursuant to an application submitted under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " or ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, {"#tail": " a drug that\n\t\t\t (i) contains the same active moiety; (ii) is an abuse-deterrent drug, and (iii)\n\t\t\t has not been discontinued from marketing; or", "@entity-type": "act", "#text": "(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}], "#text": "(7)(A) such drug has been formulated for oral administration; (B) such\n\t\t\t drug contains as an active moiety a controlled substance that has been\n\t\t\t classified as opium, an opiate, or a derivative thereof, as such terms are\n\t\t\t defined or used in "}, {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "subsection\n\t\t\t (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, "#text": "(6) the\n\t\t\t application failed to contain the patent information prescribed by "}], "#text": "by inserting\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HC676346F9B404CED9341DC778406A8A3", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "(7) based on fair"}, {"#tail": ";", "#text": "(8) based on\n\t\t\t fair"}], "#text": "by striking\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H48B4E4FAB0FB4D858744568EBEE20574", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "clauses (1) through (6)"}, {"#tail": "; and", "#text": "paragraphs (1)\n\t\t\t through (7)"}], "#text": "by striking\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H21BD89F45F664E3C8E9442AD0339E99B", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " before ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may issue an order approving an application, even if\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " applies, upon a finding that ", "@entity-type": "act", "#text": "paragraph (7)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:d/p:7"}, {"#tail": " and\n\t\t\t ", "@entity-type": "act", "#text": "paragraphs (1) through (6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:d/p:1..6"}, {"#tail": " do not apply and that such approval is necessary either to\n\t\t\t prevent or alleviate a drug shortage or to otherwise address a significant\n\t\t\t unmet public health need.", "@entity-type": "act", "#text": "paragraph (8)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:d/p:8"}], "#text": "The "}, {"#tail": ".", "#text": "As used in this subsection and\n\t\t\t subsection (e)"}], "#text": "by inserting\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H2D13743E3A1349F9A5C3CFE16829A1E1", "#text": "\n          "}], "#text": "\n        ", "@id": "HFF1B77CD1B304BB89D009C3B45C4CD9A"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t (", "@entity-type": "act", "#text": "Section 505(j) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 355(j)", "@value": "usc/21/355/j"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Generic\n\t\t\t drugs"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "paragraph\n\t\t\t (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2"}, "#text": "in "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "H060065DC852E4DF381A1EFBD772DB308", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subparagraph\n\t\t\t (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A"}, "#text": "\n              "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "clause (vii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:vii"}, "#text": "in\n\t\t\t ", "quote": {"#tail": " at the end;", "#text": "and"}}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "H1AC47B4BF4624E88B07F05993A7B8F1E", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking the period at the end and inserting ", "@entity-type": "act", "#text": "clause (viii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:viii"}, "#text": "in\n\t\t\t ", "quote": {"#tail": ";", "#text": ";\n\t\t\t and"}}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "HDD090971E1604A61A161712ED372DE68", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " the following:", "@entity-type": "act", "#text": "clause (viii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:viii"}, "#text": "by\n\t\t\t inserting after "}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n              ", "#text": ";\n\t\t\t\tand"}, "#tail": "\n\t\t\t\t\t\t", "clause": {"@indent": "up2", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "if the listed drug is an\n\t\t\t\tabuse-deterrent drug due to its physicochemical properties, information from\n\t\t\t\tcomparative in vitro, in vivo, or other testing, or some combination thereof,\n\t\t\t\tas appropriate based on the type of data submitted for the listed drug, that\n\t\t\t\tdemonstrates the new drug resists manipulation or the effect of manipulation to\n\t\t\t\ta degree at least comparable to the listed\n\t\t\t\tdrug."}, "enum": {"#tail": "\n                  ", "#text": "(ix)"}, "#text": "\n                  ", "@id": "HFB0AA62BDDE841D6B96C9224626068CC"}, "#text": "\n\t\t\t\t\t\t\t\t", "@id": "H15964036F48B4815A3E13293204245E0"}, "#text": "\n              ", "@id": "HB503D61A428642ABA29F0CFC62C86492"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "quote": [{"#tail": " and inserting ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "clauses (i) through (viii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:i..viii"}, "#text": "\n                  "}, {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "clauses (i)\n\t\t\t through (ix)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:i..ix", "@proposed": "true"}, "#text": "\n                  "}], "#text": "in\n\t\t\t the continuation text at the end of the subparagraph, by striking\n\t\t\t "}, "enum": {"#tail": "\n              ", "#text": "(iv)"}, "@id": "HBB5A636ADFD24A0DA04C05A59DE5DB93", "#text": "\n              "}], "#text": "\n            ", "@id": "H9B5791737A2E452A87EB03E0D5A03567"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subparagraph\n\t\t\t (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:A/sp:C"}, "#text": "in "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:C/cl:i"}, "#text": "in\n\t\t\t ", "quote": {"#tail": " at the end;", "#text": "or"}}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "HC34C6C876E5E499E95014F7941071559", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking the period at the end and inserting ", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:C/cl:ii"}, "#text": "in\n\t\t\t ", "quote": {"#tail": "; and", "#text": ";\n\t\t\t or"}}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H0F90737BB30A4F7E9B1DBCC87D6A2D0F", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "by\n\t\t\t adding at the end the following:"}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n              ", "#text": ";"}, "#tail": "\n\t\t\t\t\t\t", "clause": {"@indent": "up2", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "that the listed drug is an\n\t\t\t\tabuse-deterrent drug and one or more of the new drug\u2019s active moieties differ\n\t\t\t\tin any material respect (in amount or otherwise) from those of the listed\n\t\t\t\tdrug."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "#text": "\n                  ", "@id": "HABA3059CB47247CAA29D362A4DD4C932"}, "#text": "\n\t\t\t\t\t\t\t\t", "@id": "H47DF82114EE24C8B808F6FC836C31447"}, "#text": "\n              ", "@id": "H7DA89972303A403FAD0A82BAD174B215"}], "#text": "\n            ", "@id": "HC05A6923EAD9417E9C15754EC94B1E59"}]}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",\n\t\t\t by adding at the end the following:", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5"}, "#text": "in "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": ";\n\t\t\t\tand"}, "#tail": "\n\t\t\t\t", "subparagraph": {"@indent": "up2", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and thereafter the listed drug\n\t\t\t\treferred to in the application becomes an abuse-deterrent drug, the drug so\n\t\t\t\tapproved shall not be considered to be bioequivalent to, or to have the same\n\t\t\t\ttherapeutic effect as, the listed drug (as described in ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2"}, {"#tail": ")\n\t\t\t\tunless and until the drug so approved has been found by the ", "@entity-type": "act", "#text": "paragraph (2)(A)(iv)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:iv"}, {"#tail": " to meet\n\t\t\t\tthe requirements of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(2)(A)(ix)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:ix"}], "#text": "If a drug has been approved pursuant to an\n\t\t\t\tapplication submitted under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(G)"}, "#text": "\n              ", "@id": "H43EB4210BB1849AEB48E266559B6AA89"}, "#text": "\n\t\t\t\t\t\t", "@id": "H9C42264D859943F287716A5B5C75B859"}, "#text": "\n          ", "@id": "H151383971E844231BAD39F40839EE71A"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "paragraph\n\t\t\t (6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:6"}, "#text": "in "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "#text": "\n          ", "@id": "H76F5C206CC684792BAF105EEBC77055B", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "(6) If a drug"}, {"#tail": ";", "#text": "(6)(A) If a\n\t\t\t drug"}], "#text": "by striking\n\t\t\t "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H54808CDBAB064951B20B5A1FE5E38C4B", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "(A) for the"}, {"#tail": ";", "#text": "(i) for the"}], "#text": "by striking\n\t\t\t "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H1263C5FCDC1647E0B11C34714B4DA367", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "(B) if the"}, {"#tail": "; and", "#text": "(ii) if the"}], "#text": "by striking\n\t\t\t "}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "H0381C4C6F83148CA8E5EFED644DDB6C5", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "by adding at the\n\t\t\t end the following:"}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "subparagraph": {"@indent": "up2", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a withdrawal or suspension of a drug formulated for oral\n\t\t\t\tadministration shall be considered to have been for safety or effectiveness\n\t\t\t\treasons if\u2014", "@entity-type": "act", "#text": "paragraph (7)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:7/sp:C"}, "#text": "For purposes of this paragraph and\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the approval of a listed drug, which\n\t\t\t\tis not an abuse-deterrent drug, is withdrawn or suspended, or a listed drug,\n\t\t\t\twhich is not an abuse-deterrent drug, is withdrawn from sale; and"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H1F379CA323494C6B967E496BC180B013", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " has previously approved\n\t\t\t\tpursuant to an application under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " a drug that\u2014", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}], "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "is in the same dosage form;"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "H5C4B59705F58423B8C91F9C04038CBB7", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "contains the same controlled\n\t\t\t\tsubstance as an active moiety;"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "H850E993C11AF4AA39C03D97C848F9AD5", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "is an abuse-deterrent drug;\n\t\t\t\tand"}, "enum": {"#tail": "\n                    ", "#text": "(III)"}, "@id": "HF53C16910FB74733AA9AF8614BA1690A", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "has not been discontinued from\n\t\t\t\tmarketing."}, "enum": {"#tail": "\n                    ", "#text": "(IV)"}, "@id": "H09A694961893464FA18D94845DA93ADF", "#text": "\n                    "}], "#text": "\n                  ", "@id": "HAB6660B0871C404BBE2BBACE04F934E9"}], "#text": "\n                ", "@id": "HB8743A51C2224244AB43128554032F11"}, "#text": "\n\t\t\t\t\t\t\t", "@id": "H65FB8556FA4A45ACBC4935296894BE10"}, "#text": "\n            ", "@id": "H4CB2FBF9E9BE4BF6BC5DF3D2BC2AE277"}]}], "#text": "\n        ", "@id": "HA1CC7E26E5D249148CA862390385F2D7"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is\n\t\t\t amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 505(e)\n\t\t\t of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:e"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 355(e)", "@value": "usc/21/355/e"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n        ", "#text": "Withdrawal of\n\t\t\t previously approved brand name and generic drugs"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " before ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "; (B)\n\t\t\t the drug is formulated for oral administration; (C) the drug is not an\n\t\t\t abuse-deterrent drug; and (D) the ", "@entity-type": "act", "#text": "section 102 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:102"}, {"#tail": " has previously approved pursuant to\n\t\t\t an application submitted under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " or ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, {"#tail": " a drug that contains the\n\t\t\t same active moiety, is an abuse-deterrent drug, and has not been discontinued\n\t\t\t from marketing", "@entity-type": "act", "#text": "(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}], "#text": "or (6)(A) the drug contains as an active moiety a controlled substance\n\t\t\t that has been classified as opium, an opiate, or a derivative thereof, as such\n\t\t\t terms are defined or used in "}, {"#tail": ";\n\t\t\t and", "#text": ": ", "italic": {"#tail": "\n            ", "#text": "Provided,"}}], "#text": "by inserting\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H91BFF801A16443E49825344C64567685", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may waive the application of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " of the first sentence of this subsection in the case of a drug intended for\n\t\t\t use in a special needs population. In withdrawing (under ", "@entity-type": "act", "#text": "paragraph\n\t\t\t (6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:e/p:6"}, {"#tail": " of the\n\t\t\t first sentence of this subsection) the approval of an application with respect\n\t\t\t to any drug, the ", "@entity-type": "act", "#text": "paragraph (6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:e/p:6"}, {"#tail": " shall, on a case-by-case basis, delay the effective\n\t\t\t date of such withdrawal for a period deemed sufficient by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " to give\n\t\t\t the sponsor an opportunity to obtain approval under this section for a\n\t\t\t formulation of the drug meeting the criteria described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " of the\n\t\t\t definition of a ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:e/p:2"}, {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t 201(ss)", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:ss"}], "term": {"#tail": " in ", "#text": "abuse-deterrent drug"}, "#text": "The "}, "#text": "by adding at the\n\t\t\t end the following: "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H29DD9BFBCF8D4AD4B25298E3E4E46B87", "#text": "\n          "}], "#text": "\n        ", "@id": "HDFCB994A495042948DC93A45137FCB98"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 505(j)(7) of the Federal Food, Drug, and Cosmetic\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:7"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 355(j)(7)", "@value": "usc/21/355/j/7"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(f)"}, "header": {"#tail": "\n        ", "#text": "Listed\n\t\t\t drugs"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subparagraph": {"@indent": "up2", "#tail": "\n          ", "text": {"short-title": {"#tail": ", the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "act", "#text": "Stop Tampering of\n\t\t\t\tPrescription Pills Act of 2013", "@value": "Stop Tampering of Prescription Pills Act of 2013", "@proposed": "true"}, "#text": "\n                "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#tail": "\n\t\t\t\t\t\t", "#text": "Beginning 60 days after the date of\n\t\t\t\tthe enactment of the "}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " a list of each drug or category of drugs which the ", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:7/sp:A"}, {"#tail": " has found to\n\t\t\t\tbe abuse-deterrent drugs; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "include in the list under "}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "H8861D7CB878D4425A42B5DD28360F850", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:7/sp:A"}, "#text": "update the list under "}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "subclause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " later determines is not an\n\t\t\t\tabuse-deterrent drug; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "to remove from the list of\n\t\t\t\tabuse-deterrent drugs any drug the "}, "enum": {"#tail": "\n                ", "#text": "(I)"}, "@id": "H92DA3C36DDCA4ECB94B373E1EC1CC0B5", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to\n\t\t\t\treflect the application of ", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:7/sp:C"}, {"#tail": " to drugs that are withdrawn or\n\t\t\t\tsuspended.", "@entity-type": "act", "#text": "paragraph (6)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:6/sp:B"}], "#text": "as required by "}, "enum": {"#tail": "\n                ", "#text": "(II)"}, "@id": "HEE9448760F844CDE84EE3417FE35930A", "#text": "\n                "}], "#text": "\n              ", "@id": "H329F09A9E4D1460B84C16C992A128EF3"}], "#text": "\n            ", "@id": "HC2368798BF854F29BF4C9EE1E43D20E1"}, "#text": "\n\t\t\t\t\t", "@id": "H55B6564C75DE4249AD82ADBE2A20F054"}, "#text": "\n        ", "@id": "HA8A1DFE49ABB4ED5AA8E604EB174B9CD"}], "#text": "\n      ", "@id": "H2EDC51A2AD0847E785A2D4D067E49C73"}], "#text": "\n\t\t", "@id": "HE44FCC6F67BE45F7ACCE936795AC20DC"}}}